+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Live Cell Imaging Market - Global Outlook & Forecast Market 2022-2027

  • PDF Icon


  • 317 Pages
  • September 2022
  • Region: Global
  • Arizton
  • ID: 5661126
1h Free Analyst Time

Quick Summary:

Harness the power of live cell imaging to generate important insights for your organization. This market research report provides a comprehensive overview and evidence-based analysis of the rapidly-evolving live cell imaging market fundamental to studying cells, processes, and molecular interactions in real-time.

Live cell imaging has transformed the way scientists observe cellular activities, from studying structural components to dynamic processes and molecular localizations. The technologies involved have significantly influenced market growth and have been adopted in various fields ranging from cancer biology to cell and gene therapy, aided by advancements such as deep learning and artificial intelligence in microscopy.

Furthermore, increased funding for cell and gene therapy and technological advancements in imaging techniques are pushing the boundaries of live cell imaging possibilities. This report outlines the key market trends and drivers, segmentation analysis, geographic distribution, and competitive landscape for this dynamic and crucial field. Specially designed for senior business executives, this report will guide strategic decision-making processes, helping your organization stay abreast with the developments in live cell imaging.

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Live cell imaging is one of the popular techniques for studying live cells and investigating the biological processes in real-time. It utilizes time-lapse microscopy and careful preparation of living cell environments that have made it easier to observe cell-to-cell interactions and study the behavior of single cells and related changes within the cell. In 2021, North America accounted for the highest share of the global live cell imaging market.

Live cell imaging has revolutionized studying cells, processes, and molecular interactions. Imaging techniques for living cells allow scientists to study cell structures and processes in real-time and over time. Such factors have significantly impacted the growth of the market. A few of the most widespread applications include examining the structural components of a cell, the dynamic studying processes, and the localization of molecules.


Rising Target Patient Population

Live cell imaging is a vital tool in the study of cancer biology. Although high-resolution imaging is indispensable for studying genetic and cell signaling changes in underlying cancer, live cell imaging is essential for a deeper understanding of the function and disease mechanisms. Around 400,000 children develop cancer every year. Developed and emerging countries are facing the burden of communicable diseases. Most developing countries get exposed due to several factors that include demographic, socio-economic, and geographic conditions. Hence, the growing number of deaths and chronic conditions drive the live cell imaging market.

Deep Learning & Artificial Intelligence

The role of Artificial intelligence (AI) in life science is rapidly expanding and holds great potential for microscopy. In the past, the power of microscopy for supporting or disproving scientific hypotheses got limited by scale, and the time associated with quantifying, capturing, and analyzing large numbers of images was often prohibitive. Recently, AI has made fast inroads into many scientific fields and the world of microscopy. AI-based self-learning microscopy shows the potential to produce high throughput image analysis that is more effortless and less time-consuming. Newer AI technology allows better visualization of unlabeled live cells over a prolonged period.

Increase in Funding for Cell & Gene Therapy

The demand for regenerative medicine has increased across developed countries, and investments in cell & gene therapy have grown drastically in recent years. The public and private sectors are at the forefront of funding cell and gene therapy developers. Recently, many government organizations and private firms have started funding many biotech start-ups and research institutes that invest in the R&D of cell and gene therapy products. According to the Alliance for Regenerative Medicines, there was a 164% jump in funding for cell & gene therapy in 2019 compared to 2017.

Advancements & Newer Imaging Techniques

Live cell imaging arises from scientific interest coupled with imaging and labeling technology improvements. Putting together various technological advancements with biological interests gives scientists many more ways to use live cell imaging. In particular, exciting progress in probe development has enabled a broad array of nucleic acids, proteins, glycans, lipids, ions, metabolites, and other targets to be labeled. Many recent advancements in microscopic technologies use software that enables a better quantitative image analysis of label-free images.

Also, current microscopy techniques limit the quantity and quality of information available to researchers and clinicians and harm the living cells during long-term studies. Hence new imaging technologies are being developed to overcome various limitations. These advancements will help towards future market growth. For instance, the progress of combining 3D fluorescence imaging and holotomography microscopy has overcome some limitations.

Growing Research-based Activities

In the past two decades, the spending on R&D and the introduction of newer drugs have increased rapidly. In 2019, the pharma industry spent around $83 billion on R&D. From 2010 to 2019, the number of novel drugs were approved, whose sales increased by 60% compared with the previous decade, with a peak of 59 new drugs approved in 2018. The rising amount of R&D expenditure and the number of R&D activities in the pharmaceutical sector has led to the significant growth of the market.


  • The global live cell imaging market by product includes sub-segments by equipment, consumables, and software. In 2021, the equipment sector accounted for the highest share in the global live cell imaging market.
Under the equipment sector, live-cell imaging microscopes are opening novel and exciting avenues for studying cellular health, viability, colony formation, migration, and cellular responses to external stimuli. The demand for microscopes is at a larger scale, majorly due to the technological advancements in microscopes and increasing studies into cell behavior.
  • Fluorescence microscopy, confocal microscopy, transmitted light microscopy, and other techniques are included in the global live cell imaging market by technique. Fluorescence microscopy held the largest share of 53.68% in the global live cell imaging market in 2021. Live-cell imaging techniques are involved in a wide spectrum of imaging modalities, including widefield fluorescence, confocal, multiphoton, total internal reflection, FRET, lifetime imaging, super-resolution, and transmitted light microscopy.
  • An increasing number of investigations are using live-cell imaging techniques. Owing to these advances, live-cell imaging has become a requisite analytical tool in most cell biology laboratories. Cell biology, drug discovery, developmental biology, and stem cell are the application's primary segments of the live cell imaging market. In 2021, cell biology accounted for the highest share of 38.72% in the global live cell imaging market.
  • The end-user market includes segments by pharma & biotech companies, academic & research institutes, and others. Academic and research institutions identify promising discoveries and seek to initiate their development and commercialization. Most new insights into biology, disease, and new technologies arise in academia, funded by public grants, foundations, and institutional funds. The discovery and development of new therapies have and will likely continue to require contributions from academic institutions and the biopharmaceutical industry.

Segmentation by Product Type

  • Equipment
  • Consumables
  • Software

Segmentation by Technique

  • Fluorescence microscopy
  • Confocal microscopy
  • Transmitted light microscopy
  • Others

Segmentation by Application

  • Cell Biology
  • Drug Discovery
  • Developmental Biology
  • Stem Cells

Segmentation by End-Users

  • Pharma & Biotech Companies
  • Academic & research centers
  • Others


By geography, the report includes North America, Europe, APAC, Latin America, and the Middle East & Africa. In 2021, North America accounted for the highest share of the global live cell imaging market.

Live cell imaging systems are used for diagnostics purposes, drug discovery & development, and precision medicine. The increase in healthcare expenditures and funding for R&D activities for live cells-driven drug discovery, development, and personalized medicine is one of the major driving factors for leading the North American region. Europe holds the second-largest share of the global market, owing to a growing patient population in need of new treatments such as stem cell therapy and gene therapy, an increasing number of drug approvals for precision medicine, government funding for research-based activities, rapid advancements in live cell imaging, and a variety of other factors.

The APAC region will likely witness the fastest growth in the global live cell imaging market. The significant factors behind this growth can be due to the constant rise in cancers and infectious diseases, growing demand for stem cell research studies, rising R&D expenditures, the increased utility of biomarkers for diagnostic purposes, rising awareness for cell & gene therapies, need for precision medicine, and advances in drug discovery & cell and biology development. However, Latin America and Middle East & Africa accounted for minimal shares in the global market.

Segmentation by Geography

  • North America
  • THE US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • APAC
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • South Africa
  • UAE


The leading players in the market are implementing various strategies such as marketing and promotional activities, mergers & acquisitions, product launches, and approvals. Also, high R&D investments and boosting distribution networks have helped companies enhance their market share and presence.

The global live cell imaging market includes global and regional players. Major players contributing to the market's significant shares include Agilent, Bruker, Carl Zeiss AG, Danaher, Merck KGaA, PerkinElmer, and Thermo Fisher Scientific. Other prominent players in the market include Axion (CytoSMART Technologies), Bio-Rad Laboratories, blue-ray biotech, Etaluma, Grace Bio Labs, ibidi GmbH, KEYENCE, NanoEnTek, Nanolive SA, Nikon, Olympus, and others.

Recent Developments in the Global Market

  • In 2021, CytoSMART launched CytoSMART Lux3 BR, a new type of bright-field microscope, i.e., a live-cell imaging microscope equipped with a high-quality CMOS camera to assist label-free cell imaging procedures.
  • In 2021, the Zeiss group announced that they would launch Zeiss Visioner 1, a Zeiss live cell imaging system, an innovative digital microscope that facilitates real-time all-in-one focus via a micro-mirror array system.
  • In 2020, CytoSMART Technologies launched CytoSMART Multi Lux, a remote live cell imaging system.

Key Vendors

  • Danaher
  • Agilent Technologies
  • PerkinElmer
  • Merck KGaA
  • Thermo Fisher Scientific

Other Prominent Vendors

  • Axion BioSystems
  • BD
  • Bio-Rad Laboratories
  • Blue-Ray Biotech
  • Bruker
  • Eppendorf
  • Etaluma
  • Grace Bio-Labs
  • ibidi GmbH
  • Intelligent Imaging Innovations
  • Logos Biosystems
  • NanoEntek
  • Nanolive SA
  • Nikon
  • Evident
  • ONI
  • Oxford Instruments
  • Phase Focus
  • Phase Holographic Imaging PHI AB
  • Proteintech Group
  • Sartorius AG
  • Sony Biotechnology
  • Tomocube


1. What is the expected live cell imaging market size by 2027?
2. What is the live cell imaging market growth?
3. What are the latest trends in the live cell imaging market?
4. Who are the market leaders in the global live cell imaging market?
5. Which region has the largest live cell imaging market share?

Table of Contents

1 Research Methodology2 Research Objectives3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of the Study
4.3.1 Market Segmentation by Product
4.3.2 Market Segmentation by Technique
4.3.3 Market Segmentation by Application
4.3.4 Market Segmentation by End-User
4.3.5 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
8 Premium Insights
8.1 Global Live-Cell Imaging Market Scenario
8.1.1 Market Segmentations
8.1.2 Competitive Landscape
8.1.3 Recent Developments in Global Live-Cell Imaging Market
9 Market Opportunities & Trends
9.1 Deep Learning & Artificial Intelligence Enhance Live-Cell Imaging Techniques
9.2 Increased Investments in Cell & Gene Therapy Products
9.3 Tracking Solutions for Live-Cell Imaging
9.4 Advances in Live-Cell Imaging
10 Market Growth Enablers
10.1 Rise in Number of Patients With Cancers & Infectious Diseases
10.2 Adoption of Hcs Methods
10.3 New Techniques in Live-Cell Imaging
10.4 Growth in R&D Activities in Pharmaceutical Industry
11 Market Restraints
11.1 High Cost of Live-Cell Imaging Systems
11.2 Cell Viability & Cellular Environment Maintenance Challenges
11.3 Phototoxicity & Photobleaching in Fluorescence Microscopy
12 Market Landscape
12.1 Market Overview
12.2 Market Size & Forecast
12.2.1 Insights by Product
12.2.2 Insights by Technique
12.2.3 Insights by Application
12.2.4 Insights by End-User
12.2.5 Insights by Geography
12.3 Five Forces Analysis
12.3.1 Threat of New Entrants
12.3.2 Bargaining Power of Suppliers
12.3.3 Bargaining Power of Buyers
12.3.4 Threat of Substitutes
12.3.5 Competitive Rivalry
13 Product
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Equipment
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Equipment: Geography Segmentation
13.4 Consumables
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Consumables: Geography Segmentation
13.5 Software
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.5.3 Software: Geography Segmentation
14 Technique
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Fluorescence Microscopy
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Fluorescence Microscopy: Geography Segmentation
14.4 Confocal Microscopy
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Confocal Microscopy: Geography Segmentation
14.5 Transmitted Light Microscopy
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Transmitted Light Microscopy: Geography Segmentation
14.6 Others
14.6.1 Market Overview
14.6.2 Market Size & Forecast
14.6.3 Others: Geography Segmentation
15 Application
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Cell Biology
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.3.3 Cell Biology: Geography Segmentation
15.4 Drug Discovery
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.4.3 Drug Discovery: Geography Segmentation
15.5 Developmental Biology
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.5.3 Developmental Biology: Geography Segmentation
15.6 Stem Cell Research
15.6.1 Market Overview
15.6.2 Market Size & Forecast
15.6.3 Stem Cell Research: Geography Segmentation
16 End-User
16.1 Market Snapshot & Growth Engine
16.2 Market Overview
16.3 Pharma & Biotech Companies
16.3.1 Market Overview
16.3.2 Market Size & Forecast
16.3.3 Pharma & Biotech Companies: Geography Segmentation
16.4 Academic & Research Institutes
16.4.1 Market Overview
16.4.2 Market Size & Forecast
16.4.3 Academic & Research Institutes: Geography Segmentation
16.5 Others
16.5.1 Market Overview
16.5.2 Market Size & Forecast
16.5.3 Others: Geography Segmentation
17 Geography
17.1 Market Snapshot & Growth Engine
17.2 Geographic Overview
18 North America
18.1 Market Overview
18.2 Market Size & Forecast
18.2.1 North America: Product
18.2.2 North America: Technique
18.2.3 North America: Application
18.2.4 North America: End-User
18.3 Key Countries
18.3.1 Us: Market Size & Forecast
18.3.2 Canada: Market Size & Forecast
19 Europe
19.1 Market Overview
19.2 Market Size & Forecast
19.2.1 Europe: Product
19.2.2 Europe: Technique
19.2.3 Europe: Application
19.2.4 Europe: End-User
19.3 Key Countries
19.3.1 Germany: Market Size & Forecast
19.3.2 France: Market Size & Forecast
19.3.3 Uk: Market Size & Forecast
19.3.4 Italy: Market Size & Forecast
19.3.5 Spain: Market Size & Forecast
20 Apac
20.1 Market Overview
20.2 Market Size & Forecast
20.2.1 Apac: Product
20.2.2 Apac: Technique
20.2.3 Apac: Application
20.2.4 Apac: End-User
20.3 Key Countries
20.3.1 China: Market Size & Forecast
20.3.2 Japan: Market Size & Forecast
20.3.3 India: Market Size & Forecast
20.3.4 South Korea: Market Size & Forecast
20.3.5 Australia: Market Size & Forecast
21 Latin America
21.1 Market Overview
21.2 Market Size & Forecast
21.2.1 Latin America: Product
21.2.2 Latin America: Technique
21.2.3 Latin America: Application
21.2.4 Latin America: End-User
21.3 Key Countries
21.3.1 Brazil: Market Size & Forecast
21.3.2 Mexico: Market Size & Forecast
21.3.3 Argentina: Market Size & Forecast
22 Middle East & Africa
22.1 Market Overview
22.2 Market Size & Forecast
22.2.1 Middle East & Africa: Product
22.2.2 Middle East & Africa: Technique
22.2.3 Middle East & Africa: Application
22.2.4 Middle East & Africa: End-User
22.3 Key Countries
22.3.1 Turkey: Market Size & Forecast
22.3.2 Saudi Arabia: Market Size & Forecast
22.3.3 South Africa: Market Size & Forecast
22.3.4 Uae: Market Size & Forecast
23 Competitive Landscape
23.1 Competition Overview
23.2 Market Share Analysis
23.2.1 Danaher
23.2.2 Agilent Technologies
23.2.3 Perkinelmer
23.2.4 Merck Kgaa
23.2.5 Zeiss
23.2.6 Thermo Fisher Scientific
24 Key Company Profiles
24.1 Danaher
24.1.1 Business Overview
24.1.2 Danaher in Global Live-Cell Imaging Market
24.1.3 Product Offerings
24.1.4 Key Strategies
24.1.5 Key Strengths
24.1.6 Key Opportunities
24.2 Agilent Technologies
24.2.1 Business Overview
24.2.2 Agilent Technologies in Global Live-Cell Imaging Market
24.2.3 Product Offerings
24.2.4 Key Strategies
24.2.5 Key Strengths
24.2.6 Key Opportunities
24.3 Perkinelmer
24.3.1 Business Overview
24.3.2 Perkinelmer in Global Live-Cell Imaging Market
24.3.3 Product Offerings
24.3.4 Key Strategies
24.3.5 Key Strengths
24.3.6 Key Opportunities
24.4 Merck Kgaa
24.4.1 Business Overview
24.4.2 Merck Kgaa in Global Live-Cell Imaging Market
24.4.3 Product Offerings
24.4.4 Key Strategies
24.4.5 Key Strengths
24.4.6 Key Opportunities
24.5 Zeiss
24.5.1 Business Overview
24.5.2 Zeiss in Global Live-Cell Imaging Market
24.5.3 Product Offerings
24.5.4 Key Strategies
24.5.5 Key Strengths
24.5.6 Key Opportunities
24.6 Thermo Fisher Scientific
24.6.1 Business Overview
24.6.2 Thermo Fisher Scientific in Global Live-Cell Imaging Market
24.6.3 Product Offerings
24.6.4 Key Strategies
24.6.5 Key Strengths
24.6.6 Key Opportunities
25 Other Prominent Vendors
25.1 Axion Biosystems
25.1.1 Business Overview
25.1.2 Product Offerings
25.2 Bd
25.2.1 Business Overview
25.2.2 Product Offerings
25.3 Bio-Rad Laboratories
25.3.1 Business Overview
25.3.2 Product Offerings
25.4 Blue-Ray Biotech
25.4.1 Business Overview
25.4.2 Product Offerings
25.5 Bruker
25.5.1 Business Overview
25.5.2 Product Offerings
25.6 Eppendorf
25.6.1 Business Overview
25.6.2 Product Offerings
25.7 Etaluma
25.7.1 Business Overview
25.7.2 Product Offerings
25.8 Grace Bio-Labs
25.8.1 Business Overview
25.8.2 Product Offerings
25.9 Ibidi GmbH
25.9.1 Business Overview
25.9.2 Product Offerings
25.10 Intelligent Imaging Innovations
25.10.1 Business Overview
25.10.2 Product Offerings
25.11 Keyence Corporation
25.11.1 Business Overview
25.11.2 Product Offerings
25.12 Logos Biosystems
25.12.1 Business Overview
25.12.2 Product Offerings
25.13 Nanoentek
25.13.1 Business Overview
25.13.2 Product Offerings
25.14 Nanolive Sa
25.14.1 Business Overview
25.14.2 Product Offerings
25.15 Nikon
25.15.1 Business Overview
25.15.2 Product Offerings
25.16 Evident
25.16.1 Business Overview
25.16.2 Product Offerings
25.17 Oni
25.17.1 Business Overview
25.17.2 Product Offerings
25.18 Oxford Instruments
25.18.1 Business Overview
25.18.2 Product Offerings
25.19 Phase Focus
25.19.1 Business Overview
25.19.2 Product Offerings
25.20 Phase Holographic Imaging Phi Ab
25.20.1 Business Overview
25.20.2 Product Offerings
25.21 Proteintech Group
25.21.1 Business Overview
25.21.2 Product Offerings
25.22 Sartorius AG
25.22.1 Business Overview
25.22.2 Product Offerings
25.23 Sony Biotechnology
25.23.1 Business Overview
25.23.2 Product Offerings
25.24 Tomocube
25.24.1 Business Overview
25.24.2 Product Offerings
26 Report Summary
26.1 Key Takeaways
26.2 Strategic Recommendations
27 Quantitative Summary
27.1 Market by Product
27.1.1 North America: Product Segmentation
27.1.2 Europe: Product Segmentation
27.1.3 Apac: Product Segmentation
27.1.4 Latin America: Product Segmentation
27.1.5 Middle East & Africa: Product Segmentation
27.2 Market by Technique
27.2.1 North America: Technique Segmentation
27.2.2 Europe: Technique Segmentation
27.2.3 Apac: Technique Segmentation
27.2.4 Latin America: Technique Segmentation
27.2.5 Middle East & Africa: Technique Segmentation
27.3 Market by Application
27.3.1 North America: Application Segmentation
27.3.2 Europe: Application Segmentation
27.3.3 Apac: Application Segmentation
27.3.4 Latin America: Application Segmentation
27.3.5 Middle East & Africa: Application Segmentation
27.4 Market by End-User
27.4.1 North America: End-User Segmentation
27.4.2 Europe: End-User Segmentation
27.4.3 Apac: End-User Segmentation
27.4.4 Latin America: End-User Segmentation
27.4.5 Middle East & Africa: End-User Segmentation
27.5 Market by Geography
27.5.1 Equipment: Geography Segmentation
27.5.2 Consumables: Geography Segmentation
27.5.3 Software: Geography Segmentation
27.5.4 Fluorescence Microscopy: Geography Segmentation
27.5.5 Confocal Microscopy: Geography Segmentation
27.5.6 Transmitted Light Microscopy: Geography Segmentation
27.5.7 Others: Geography Segmentation
27.5.8 Cell Biology: Geography Segmentation
27.5.9 Drug Discovery: Geography Segmentation
27.5.10 Developmental Biology: Geography Segmentation
27.5.11 Stem Cell Research: Geography Segmentation
27.5.12 Pharma & Biotech Companies: Geography Segmentation
27.5.13 Academic & Research Institutes: Geography Segmentation
27.5.14 Others: Geography Segmentation
28 Appendix
28.1 Abbreviations


Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.

Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.